title: Acute reserpine administration elicits long-term spontaneous oral dyskinesia.
abstract: Chronic reserpine administration produces persistent oral dyskinesia accompanied by severe dopamine depletion in the caudate-putamen. The present study examined whether these behavioral and neurochemical effects would persist following acute reserpine administration. Acute administration of reserpine (1 mg/kg, s.c.) produced spontaneous oral dyskinesia that persisted above control levels for at least 84 days. Reserpine also produced a 74% depletion of dopamine in the caudate-putamen relative to vehicle treatment at 3 days post-injection, but did not significantly alter dopamine in the caudate-putamen at 84 days post-injection. The finding that reserpine-induced oral dyskinesia persisted despite repletion of dopamine in the caudate-putamen suggests that the persistent neuropathological change underlying this behavior occurs in a neural pathway other than the dopaminergic nigrostriatal pathway.
authors.affiliation: Department of Psychology, Arizona State University, Tempe 85287-1104, USA.
authors.forename: A N
authors.initials: AN
authors.lastname: Sussman
authors.forename: L T
authors.initials: LT
authors.lastname: Tran-Nguyen
authors.forename: J L
authors.initials: JL
authors.lastname: Neisewander
mesh_terms: D000818:Animals; D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000633:toxicity*; D001921:Brain / Q000187:drug effects / Q000378:metabolism; D004298:Dopamine / Q000378:metabolism; D004409:Dyskinesia, Drug-Induced / Q000378:metabolism / Q000503:physiopathology*; D008297:Male; D051381:Rats; D017207:Rats, Sprague-Dawley; D012110:Reserpine / Q000008:administration & dosage / Q000633:toxicity*; D014059:Tongue / Q000503:physiopathology*
chemical_list: D014150:Antipsychotic Agents; D012110:Reserpine; D004298:Dopamine